Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Aug 10, 2018
Document Date
Aug 3, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
HAYES JOHN T.